From: Analysis of breast cancer subtypes by AP-ISA biclustering
Class type | Term (Enrichiment type) | P-value | significant genes |
---|---|---|---|
Normal-like | regulation of cell proliferation (Gene Ontology) | 4.38E-10 | CDKN1C;TXNIP;DPT;EDNRB; KL; FIGF;ANXA1;NRG1;HOXA5; ID4; ID4;IGF1;IGFBP6;AQP1;KIT;AQP1; LIFR;PPARG;PRNP;NDRG2; CAV1 PTN;PTPRM;RBP4;CX3CL1; CAV2; SFRP1;TGFBR2;TGFBR3; KLF4; KRT5;PPAP2B;KRT17;CD36; RBP4; |
regulation of multicellular organismal process (Gene Ontology) | 1.03E-09 | ||
cell differentiation (Gene Ontology) | 1.07E-08 | ||
PPAR signaling pathway (KEGG Pathways) | 4.58E-04 | ||
HER2+ | single-organism process | 1.29E-04 | ERBB2;FGFR4;GRB7;GSK3B; FA2H; PSMD3;BIK;CDC6;CLTC;GSK3B; ODF2;RAP1GAP;S100A8;SDC1;CDC6; STX1A;TMSB10;SNF8;FHOD1; EAF2;VPS37B;WIPF2;TCAP;STARD3; |
epidermal growth factor receptor signaling pathway (Gene Ontology) | 6.944E-03 | ||
ERBB signaling pathway (Gene Ontology) | 7.514E-03 | ||
Basal-like | cell cycle process | 1.09E-05 | CDK6;CDKN2A;MSH2;FZD9; FABP7; LY6D;BCL11A;CCNE1;CDC20; MIA; CDK6;CDKN2A;CENPA;FANCA; FOXC1;STMN1;MSH2;TTK;EN1; CDK2AP1;RAD54L;CDC123;DSC2; GTPBP4;PHGDH;CDCA8;B3GNT5; CENPN;TTYH1;SUV39H2;ROPN1; CRABP1;KLK6; VGLL1;SERPINB5; |
lymphocyte differentiation (Gene Ontology) | 1.019E-03 | ||
B cell activation (Gene Ontology) | 8.673E-03 | ||
p53 signaling pathway (KEGG Pathways) | 3.15E-04 | ||
Pathways in cancer (KEGG Pathways) | 4.489E-03 | ||
Luminal-5 | mammary gland epithelium development | 1.15E-05 | CCND1;ESR1;GATA3;TBX3; BTF3; WNT3;BCL2;CELSR2;TLE3;CGA; RNF43;PVALB;CPB1;SLC1A2; SKP1A; C5orf30;SLC16A6;BEX1;GLDC;HAGH; ZNF24;LRBA;C6orf211;YPEL3;COX6C; LAMA3;MKL2;RAD17;BCAS1; CGN; SERPINA5;HSPB8;COX17;ING2; |
Wnt signaling pathway (Gene Ontology) | 7.896E-03 | ||
CD8-positive, alpha-beta T cell lineage commitmen (Gene Ontology) | 4.294E-03 | ||
Luminal-6 | Glutamate receptor signaling pathway (Gene Ontology) | 2.316E-03 | BCL2;WNT3;ESR1;SERP1;PIGT; TLE3;STC1;ARNT2;PKIB;ZFX; HAGH; IGBP1;HPN;DNAJC12;TBCA;BCAS1; CCNH;ACBD4;GRIA2;CYP2A7;BAI2; GRIA1;XBP1;SIAH2;CPEB4; MAP2K4; SLC27A2;PNPLA4;SLC1A2; MAST4; CYB5R1;CARTPT;RABEP1;RAD17; COX6C;QDPR;SEC11C; |
CD8-positive, alpha-beta T cell lineage commitment (Gene Ontology) | 3.87E-03 | ||
response to insulin-like growth factor stimulus (Gene Ontology) | 7.726E-03 | ||
Retinol metabolism (KEGG Pathways) | 4.07E-03 | ||
Luminal-9 | CD8-positive, alpha-beta T cell lineage commitment (Gene Ontology) | 4.717E-03 | XBP1;BCL2;C3orf18;CIRBP;GAD1; PKIB;APH1B;NAT1;RAB30; ABAT; BCL2;MYO5C;CA12;SIAH2;MKL2; TTC12;REPS2;NPY1R;KIAA1370; NAT2;RALGPS2;CYBRD1;MUC1; RAB31;RLN2;NTN4;MAP2K4; MAST4;GALNT10;MYB;ESR1; SREBF1;GFALS;TLE3;XBP1; ACBD4;STC2;ABAT; |
response to insulin-like growth factor stimulus (Gene Ontology) | 9.412E-03 | ||
beta-Alanine metabolism (KEGG Pathways) | 5.476E-03 |